Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: TAT-modified serum albumin nanoparticles for sustained-release of tetramethylpyrazine and improved targeting to spinal cord injury

Fig. 2

In vitro characterization of Blank-NPs, TMP-NPs and TAT-TMP-NPs. Particle size distribution and TEM images of Blank-NPs (a), TMP-NPs (c) and TAT--TMP-NPs (e). Apparent zeta potential distribution of Blank-NPs (b), TMP-NPs (d) and TAT-TMP-NPs (f) were measured by Malvern Particle Size Analyzer. Results are presented as means ± SD (n = 3). Drug release behaviors of TMP, TMP-NPs and TAT-TMP-NPs were assessed in PBS medium (pH 7.4) at 37 °C and stirred at a speed of 70 rpm for 96 h (g). The bar in a, c and e is 100 nm

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us